Kostman J R, DiNubile M J
Cooper Hospital/University Medical Center, Robert Wood Johnson Medical School, Camden, New Jersey.
Ann Intern Med. 1993 Jun 1;118(11):883-8. doi: 10.7326/0003-4819-118-11-199306010-00009.
To describe nodular lymphangitis by reviewing the clinical and epidemiologic features of this disease with an emphasis on distinguishing specific etiologic agents.
English-language articles were identified through a MEDLINE search (1966 to September 1992) using sporotrichosis, lymphangitis, and sporotrichoid as key words; additional references were selected from the bibliographies of identified articles. In addition, three new patients with nodular lymphangitis are described.
One hundred fifty articles were reviewed to determine details of the etiologic agents and clinical signs and symptoms of patients with nodular lymphangitis.
Nodular lymphangitis develops most commonly after cutaneous inoculation with Sporothrix schenckii, Nocardia brasiliensis, Mycobacterium marinum, Leishmania braziliensis, and Francisella tularensis. The setting in which infection is acquired is useful in differentiating among the various organisms causing infection. Sporotrichosis and leishmaniasis can have longer incubation periods than do the other common causes of nodular lymphangitis. A painful ulcer at the site of the initial lesion suggests tularemia; frankly purulent drainage often accompanies infections with Francisella and Nocardia species. Ulcerated or suppurating lymphangitic nodules occur commonly with Nocardia infections. Patients with nodular lymphangitis who fail to respond to empiric treatment for sporotrichosis should be evaluated for other organisms with appropriate biopsies and cultures.
Nodular lymphangitis has distinctive clinical signs and symptoms, most commonly due to infection with a limited number of organisms. A detailed history, accompanied by information obtained from skin biopsy specimens using appropriate stains and cultures, should allow specific, effective therapy for most of these infections.
通过回顾结节性淋巴管炎的临床和流行病学特征,重点区分特定病原体,来描述结节性淋巴管炎。
通过医学文献数据库(MEDLINE,1966年至1992年9月)检索英文文章,使用孢子丝菌病、淋巴管炎和孢子丝菌样作为关键词;从已识别文章的参考文献中选择其他参考文献。此外,描述了3例新的结节性淋巴管炎患者。
对150篇文章进行了综述,以确定结节性淋巴管炎患者病原体的详细信息以及临床体征和症状。
结节性淋巴管炎最常发生于皮肤接种申克孢子丝菌、巴西奴卡菌、海分枝杆菌、巴西利什曼原虫和土拉弗朗西斯菌之后。感染获得的背景有助于区分引起感染的各种病原体。孢子丝菌病和利什曼病的潜伏期可能比结节性淋巴管炎的其他常见病因更长。初始病变部位的疼痛性溃疡提示兔热病;弗朗西斯菌和奴卡菌属感染常伴有明显的脓性引流。溃疡性或化脓性淋巴管结节在奴卡菌感染中很常见。对经验性治疗孢子丝菌病无反应的结节性淋巴管炎患者,应通过适当的活检和培养评估其他病原体。
结节性淋巴管炎具有独特的临床体征和症状,最常见的原因是感染少数几种病原体。详细的病史,结合从皮肤活检标本中通过适当的染色和培养获得的信息,应能为大多数此类感染提供特异性、有效的治疗。